Sodium Gluconate, Gluconic Acid, and Derivative Products From China and France, 3021 [2018-00984]
Download as PDF
Federal Register / Vol. 83, No. 14 / Monday, January 22, 2018 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–590 and 731–
TA–1397–98 (Preliminary)]
Sodium Gluconate, Gluconic Acid, and
Derivative Products From China and
France
Determinations
On the basis of the record 1 developed
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that there is a reasonable indication that
an industry in the United States is
threatened with material injury by
reason of imports of sodium gluconate,
gluconic acid, and derivative products
from China, provided for in subheadings
2918.16.10, 2918.16.50 and 2932.20.50
of the Harmonized Tariff Schedule of
the United States, that are alleged to be
sold in the United States at less than fair
value (‘‘LTFV’’) and to be subsidized by
the government of China. The
Commission further determines that
there is no reasonable indication that an
industry in the United States is
materially injured or threatened with
material injury by reason of imports of
sodium gluconate, gluconic acid, and
derivative products from France that are
alleged to be sold in the United States
at LTFV.2
ethrower on DSK3G9T082PROD with NOTICES
Commencement of Final Phase
Investigations
Pursuant to section 207.18 of the
Commission’s rules, the Commission
also gives notice of the commencement
of the final phase of its investigations.
The Commission will issue a final phase
notice of scheduling, which will be
published in the Federal Register as
provided in section 207.21 of the
Commission’s rules, upon notice from
the Department of Commerce
(‘‘Commerce’’) of affirmative
preliminary determinations in the
investigations under sections 703(b) or
733(b) of the Act, or, if the preliminary
determinations are negative, upon
notice of affirmative final
determinations in those investigations
under sections 705(a) or 735(a) of the
Act. Parties that filed entries of
appearance in the preliminary phase of
the investigations need not enter a
separate appearance for the final phase
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
2 Chairman Rhonda K. Schmidtlein dissenting.
Chairman Schmidtlein determines that there is a
reasonable indication that an industry in the United
States is materially injured by reason of imports of
the subject product from China and France.
VerDate Sep<11>2014
19:00 Jan 19, 2018
Jkt 244001
of the investigations. Industrial users,
and, if the merchandise under
investigation is sold at the retail level,
representative consumer organizations
have the right to appear as parties in
Commission antidumping and
countervailing duty investigations. The
Secretary will prepare a public service
list containing the names and addresses
of all persons, or their representatives,
who are parties to the investigations.
Background
On November 30, 2017, PMP
Fermentation Products, Inc., Peoria,
Illinois, filed a petition with the
Commission and Commerce, alleging
that an industry in the United States is
materially injured or threatened with
material injury by reason of LTFV and
subsidized imports of sodium gluconate,
gluconic acid, and derivative products
from China and LTFV imports of
sodium gluconate, gluconic acid, and
derivative products from France.
Accordingly, effective November 30,
2017, the Commission, pursuant to
sections 703(a) and 733(a) of the Act (19
U.S.C. 1671b(a) and 1673b(a)), instituted
countervailing duty investigation No.
701–TA–590 and antidumping duty
investigation Nos. 731–TA–1397–98
(Preliminary).
Notice of the institution of the
Commission’s investigations and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register of December 6, 2017
(82 FR 57614). The conference was held
in Washington, DC, on December 21,
2017, and all persons who requested the
opportunity were permitted to appear in
person or by counsel.
The Commission made these
determinations pursuant to sections
703(a) and 733(a) of the Act (19 U.S.C.
1671b(a) and 1673b(a)). It completed
and filed its determinations in these
investigations on January 16, 2018. The
views of the Commission are contained
in USITC Publication 4756 (January
2018), entitled Sodium Gluconate,
Gluconic Acid, and Derivative Products
from China and France: Investigation
Nos. 701 TA–590 and 731–TA–1397–98
(Preliminary).
By order of the Commission.
Issued: January 16, 2018.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2018–00984 Filed 1–19–18; 8:45 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
3021
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1094]
Certain IoT Devices and Components
Thereof (IoT, the Internet of Things)—
Web Applications Displayed on a Web
Browser; Institution of Investigation
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
October 3, 2017, under section 337 of
the Tariff Act of 1930, as amended, on
behalf of Lakshmi Arunachalam, Ph.D.
of Menlo Park, California. Supplements
were filed on October 24, October 30,
and November 3, 2017. On November 7,
2017, an amended complaint was filed
with the U.S. International Trade
Commission under section 337 of the
Tariff Act of 1930, as amended, on
behalf of Lakshmi Arunachalam, Ph.D.
and WebXchange, Inc., both of Menlo
Park, California. Supplements were filed
on November 7, 13, and December 21,
2017. On December 6, 2017, the
Commission postponed the vote on
whether to institute an investigation
based on the amended complaint to
January 9, 2017. The amended
complaint alleges violations of section
337 based upon the importation into the
United States, the sale for importation,
and the sale within the United States
after importation of certain IOT devices
and components thereof (IOT, the
Internet of Things)—web applications
displayed on a web browser by reason
of infringement of certain claims of U.S.
Patent No. 7,930,340 (‘‘the ’340 patent’’),
and that an industry in the United
States exists as required by the
applicable Federal Statute. The
amended complaint further alleges
unfair methods of competition and
unfair acts (criminal and civil RICO
violations, breach of contract, theft of
intellectual property, antitrust
violations, and trade secret
misappropriation), the threat or effect of
which is to destroy or substantially
injure an industry in the United States.
The complainant requests that the
Commission institute an investigation
and, after the investigation, issue a
limited exclusion order and cease and
desist orders.
ADDRESSES: The amended complaint,
except for any confidential information
contained therein, is available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
SUMMARY:
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 83, Number 14 (Monday, January 22, 2018)]
[Notices]
[Page 3021]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00984]
[[Page 3021]]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation Nos. 701-TA-590 and 731-TA-1397-98 (Preliminary)]
Sodium Gluconate, Gluconic Acid, and Derivative Products From
China and France
Determinations
On the basis of the record \1\ developed in the subject
investigations, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that there is a reasonable indication that an industry in the
United States is threatened with material injury by reason of imports
of sodium gluconate, gluconic acid, and derivative products from China,
provided for in subheadings 2918.16.10, 2918.16.50 and 2932.20.50 of
the Harmonized Tariff Schedule of the United States, that are alleged
to be sold in the United States at less than fair value (``LTFV'') and
to be subsidized by the government of China. The Commission further
determines that there is no reasonable indication that an industry in
the United States is materially injured or threatened with material
injury by reason of imports of sodium gluconate, gluconic acid, and
derivative products from France that are alleged to be sold in the
United States at LTFV.\2\
---------------------------------------------------------------------------
\1\ The record is defined in sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
\2\ Chairman Rhonda K. Schmidtlein dissenting. Chairman
Schmidtlein determines that there is a reasonable indication that an
industry in the United States is materially injured by reason of
imports of the subject product from China and France.
---------------------------------------------------------------------------
Commencement of Final Phase Investigations
Pursuant to section 207.18 of the Commission's rules, the
Commission also gives notice of the commencement of the final phase of
its investigations. The Commission will issue a final phase notice of
scheduling, which will be published in the Federal Register as provided
in section 207.21 of the Commission's rules, upon notice from the
Department of Commerce (``Commerce'') of affirmative preliminary
determinations in the investigations under sections 703(b) or 733(b) of
the Act, or, if the preliminary determinations are negative, upon
notice of affirmative final determinations in those investigations
under sections 705(a) or 735(a) of the Act. Parties that filed entries
of appearance in the preliminary phase of the investigations need not
enter a separate appearance for the final phase of the investigations.
Industrial users, and, if the merchandise under investigation is sold
at the retail level, representative consumer organizations have the
right to appear as parties in Commission antidumping and countervailing
duty investigations. The Secretary will prepare a public service list
containing the names and addresses of all persons, or their
representatives, who are parties to the investigations.
Background
On November 30, 2017, PMP Fermentation Products, Inc., Peoria,
Illinois, filed a petition with the Commission and Commerce, alleging
that an industry in the United States is materially injured or
threatened with material injury by reason of LTFV and subsidized
imports of sodium gluconate, gluconic acid, and derivative products
from China and LTFV imports of sodium gluconate, gluconic acid, and
derivative products from France. Accordingly, effective November 30,
2017, the Commission, pursuant to sections 703(a) and 733(a) of the Act
(19 U.S.C. 1671b(a) and 1673b(a)), instituted countervailing duty
investigation No. 701-TA-590 and antidumping duty investigation Nos.
731-TA-1397-98 (Preliminary).
Notice of the institution of the Commission's investigations and of
a public conference to be held in connection therewith was given by
posting copies of the notice in the Office of the Secretary, U.S.
International Trade Commission, Washington, DC, and by publishing the
notice in the Federal Register of December 6, 2017 (82 FR 57614). The
conference was held in Washington, DC, on December 21, 2017, and all
persons who requested the opportunity were permitted to appear in
person or by counsel.
The Commission made these determinations pursuant to sections
703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It
completed and filed its determinations in these investigations on
January 16, 2018. The views of the Commission are contained in USITC
Publication 4756 (January 2018), entitled Sodium Gluconate, Gluconic
Acid, and Derivative Products from China and France: Investigation Nos.
701 TA-590 and 731-TA-1397-98 (Preliminary).
By order of the Commission.
Issued: January 16, 2018.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2018-00984 Filed 1-19-18; 8:45 am]
BILLING CODE 7020-02-P